Brian E. Toki
26Patents
17h-index
13Co-inventors
78Inventor score
Filing activity: Jan 9, 1999 → Jul 10, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7498298B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 452 | Expired |
| US6884869B2 | Pentapeptide compounds and uses related thereto | Human Necessities | 278 | Expired |
| US7659241B2 | Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease | Chemistry; Metallurgy | 247 | Expired |
| US7745394B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 149 | Active |
| US7964566B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 140 | Active |
| US7091186B2 | p-Amidobenzylethers in drug delivery agents | Human Necessities | 138 | Expired |
| US7829531B2 | Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease | Chemistry; Metallurgy | 125 | Active |
| US7994135B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 124 | Active |
| US7553816B2 | p-amidobenzylethers in drug delivery agents | Human Necessities | 106 | Expired |
| US7851437B2 | Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease | Chemistry; Metallurgy | 102 | Active |
| US7964567B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 93 | Active |
| US7098308B2 | Pentapeptide compounds and uses related thereto | Human Necessities | 56 | Expired |
| US8703714B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 50 | Active |
| US7256257B2 | Pentapeptide compounds and uses related thereto | Human Necessities | 39 | Expired |
| US8557780B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 30 | Active |
| US8163551B2 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | Chemistry; Metallurgy | 27 | Active |
| US7423116B2 | Pentapeptide compounds and uses related thereto | Human Necessities | 27 | Active |
| US8574907B2 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | Chemistry; Metallurgy | 14 | Active |
| US8906376B2 | Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease | Chemistry; Metallurgy | 12 | Active |
| US10808039B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 9 | Active |
| US8993326B2 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | Chemistry; Metallurgy | 9 | Active |
| US10414826B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 7 | Active |
| US9816069B2 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | Chemistry; Metallurgy | 5 | Active |
| US6943194B1 | Synthesis of phenstatin and prodrugs thereof | Chemistry; Metallurgy | 4 | Expired |
| US10443035B2 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.